Stockreport

Quanterix (QTRX) AD Offering Gets FDA's Breakthrough Device Tag [Yahoo! Finance]

Quanterix Corporation  (QTRX) 
US:NASDAQ Investor Relations: ir.quanterix.com/investor-relations
PDF Breakthrough Device designation to its Simoa phospho-Tau 217 (p-Tau 217) blood test for Alzheimer's Disease (AD). The company claims that the p-Tau 217 biomarker is a hi [Read more]